INNPF News and Press, Innovative Properties Inc

Innocan Pharma Engages Pain Management Expert in Preparation for Upcoming FDA Meeting Canada NewsWire HERZLIYA, Israel and CALGARY , Alberta , July 2, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"),...

Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs Canada NewsWire HERZLIYA, Israel and CALGARY, AB , June 11, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a...

Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million Canada NewsWire HERZLIYA, Israel and CALGARY, AB , May 27, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan...

FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain Canada NewsWire The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan's LPT-CBD release technology, marking a key step in the advancement of non-opioid pai...

Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey Canada NewsWire HERZLIYA, Israel and ALGARY, AB , May 9, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INN...

Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain Canada NewsWire With its submission of a Pre-IND Meeting Request Letter, Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA) for the approval of ...

Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , April 1, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a ph...

Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval. Canada NewsWire HERZLIYA, Israel and CALGARY, AB , March 25, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (...

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million Canada NewsWire NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY , Alberta ,...

Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study Canada NewsWire Innocan Announces Notice of Intention to Complete a Private Placement of Units HERZLIYA, Israel and CALGARY, Alberta...